Insights

Strategic consolidation Selexis SA is consolidating operations with KBI Biopharma to offer a streamlined, flexible partnership experience that accelerates drug development and manufacturing, presenting a unified front for clients seeking CDMO services.

Award-winning capabilities KBI Biopharma has recently earned top honors in fill-finish and cultural fit categories at the 2026 CDMO Leadership Awards, signaling strong execution in biologics manufacturing and a competitive edge to attract customers seeking reliable partner performance.

Clinical supply readiness Recent formal agreements for clinical supply manufacturing with KBI Biopharma and collaborations like TH103 with Kalaris Therapeutics indicate ongoing capacity and experience in clinical-stage support, ideal for sponsors planning phase transitions.

Preclinical to late-stage Past partnerships involving preclinical antibodies and ongoing biologics programs suggest opportunities to engage sponsors across development stages, from preclinical through fill-finish manufacturing, leveraging integrated services.

Digital and data edge Adoption of modern tech stack including AWS, Power BI, GitHub, and analytics tools positions the combined entity to offer data-driven manufacturing insights, scalable cloud-based operations, and robust project transparency for prospective clients.

Similar companies to Selexis SA

Selexis SA Tech Stack

Selexis SA uses 8 technology products and services including HubSpot Analytics, Power BI, Amazon Web Services, and more. Explore Selexis SA's tech stack below.

Media & News

Selexis SA's Email Address Formats

Selexis SA uses at least 5 email formats:
Selexis SA Email FormatsExamplePercentage
First.Last@selexis.comJohn.Doe@selexis.com
100%
FLast@kbibiopharma.comJDoe@kbibiopharma.com
94%
FiLast@kbibiopharma.comJoDoe@kbibiopharma.com
3%
First.Last@kbibiopharma.comJohn.Doe@kbibiopharma.com
2%
FirLast@kbibiopharma.comJohDoe@kbibiopharma.com
1%

Frequently Asked Questions

What is Selexis SA's phone number?

Minus sign iconPlus sign icon
You can contact Selexis SA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Selexis SA's official website and social media links?

Minus sign iconPlus sign icon
Selexis SA's official website is kbibiopharma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Selexis SA generate?

Minus sign iconPlus sign icon
As of October 2026, Selexis SA's annual revenue is estimated to be <$1M.

What is Selexis SA's SIC code and NAICS code?

Minus sign iconPlus sign icon
Selexis SA's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Selexis SA have currently?

Minus sign iconPlus sign icon
As of October 2026, Selexis SA has approximately 21 employees across 1 continents, including Europe. Key team members include Vp Operations And Ip: M. A., Vice President, Cell Line Services: S. F. and Senior Director, Cell Line Services (selexis Fused To Kbi Biopharma In April 2023): D. C. Explore Selexis SA's employee directory with LeadIQ.

What industry does Selexis SA belong to?

Minus sign iconPlus sign icon
Selexis SA operates in the Biotechnology Research industry.

What technology does Selexis SA use?

Minus sign iconPlus sign icon
Selexis SA's tech stack includes HubSpot Analytics, Power BI, Amazon Web Services, GitHub, Microsoft SQL Server, Microsoft Intune, Microsoft Active Directory and Atlassian Confluence.

What is Selexis SA's email format?

Minus sign iconPlus sign icon
Selexis SA's email format typically follows the pattern of First.Last@selexis.com. Find more Selexis SA email formats with LeadIQ.

How much funding has Selexis SA raised to date?

Minus sign iconPlus sign icon
As of October 2026, Selexis SA has raised $67K in funding. The last funding round occurred on Jun 20, 2015.

When was Selexis SA founded?

Minus sign iconPlus sign icon
Selexis SA was founded in 2001.
Selexis SA logo

Selexis SA

Biotechnology ResearchGeneva, Switzerland11-50 Employees

Selexis SA is a biotechnology research company based in Plan-les-ouates, in the Geneva region of Switzerland. It is consolidating its operations with KBI Biopharma to operate as a single organization under the KBI Biopharma name. The consolidation aims to help customers accelerate drug development and manufacturing by delivering greater flexibility and efficiency.

The combined entity operates in the contract development and manufacturing organization space, seeking to provide a smoother partner experience for clients. The company is described as a small to mid-sized biotechnology firm. Recent industry coverage notes that KBI Biopharma earned 2026 awards for cultural fit and fill-finish capabilities.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
11-50

Section iconFunding & Financials

  • $67K

    Selexis SA has raised a total of $67K of funding over 2 rounds. Their latest funding round was raised on Jun 20, 2015 as a Grant.

  • <$1M

    Selexis SA's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.